Share This

Create Your Own Business Intelligence Website   Input the stock code or the company name     Search   <01548.HK> - GENSCRIPT BIOTECH CORPORATION    Stock Screener：Biotechnology, Biotechnology HUTCHMED INNOVATIVE PHAR UNI-BIO GROUP KING INTL INV BBI LIFE SCI ESSEX BIO-TECH JACOBIO-B CANBRIDGE-B 3D MEDICINES FUDANZHANGJIANG OCUMENSION-B FRONTAGE 3SBIO IMMUNEONCO-B ASCLETIS-B INNOVENT BIO VIVA BIOTECH TOT BIOPHARM-B JUNSHI BIO EVEREST MED-B LAEKNA-B JW THERAP-B BRII-B HBM HOLDINGS-B LEPU BIO-B KEYMED BIO-B BASECARE-B CARSGEN-B RECBIO-B MABPHARM-B CLOVER BIO-B ABBISKO-B SIRNAOMICS-B WUXI XDC WUXI BIO BIOCYTOGEN-B MEILLEUREHEALTH WUXI APPTEC GIANT BIOGENE LUZHU BIOTECH-B CUTIA-B YZYBIO-B QYUNS-B HIGHTIDE-B HUA MEDICINE-B CSTONE PHARMA-B HENLIUS TIGERMED SINOMAB BIO-B CT ENTERPRISE AUSTAR JOINN BEIGENE CANSINOBIO SCICLONE PHARMA TRANSCENTA-B AIM VACCINE MEGA GENOMICS HAOHAI BIOTEC ASCENTAGE-B BOAN BIOTECH IMMUNOTECH-B SKB BIO-B ANTENGENE-B GENOR-B HAO WEN HLDGS HK LIFE SCI CRMI PFC DEVICE BIOSINO BIO-TEC NEP INTERLONG CORNERSTONE TEC HUAKANG BIOMED    Basic Datum Company name Lot P/E P/B EPS DPS GENSCRIPT BIO 2000 -56.13 2.1181 -0.3538 0.0 Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend    Related links    Related news    金斯瑞：傳奇生物藥物獲歐盟批准治療骨髓瘤   金斯瑞上季CARVYKTI貿易銷售淨額1.57億美元   金斯瑞附屬傳奇生物CARVYKTI獲FDA批准骨髓瘤二線治療   《全日總結》恆指跌1點 匯控友邦造好 醫藥股普遍受壓   《半日總結》恆指跌118點 匯控友邦逆漲 中海油服挫18%   《即日市評》恆指向下 友邦走弱 藥明系及理想捱沽  ≫More    Company Rating Date Broker Company name Rating Target 04-25  BOCOM   GENSCRIPT BIO  買入 27.75 ≫More    Company performance - Published Date Company name Turnover* Profit* % Dividend ≫More    Comment 2019-04-09　金斯瑞生物（1548）與美國強生的製藥業務楊森，共同開發用於治療多發性骨髓瘤藥物，獲歐洲藥品管理局以優先審評藥物認定，消息刺激金瑞斯昨日股價急漲25.5%，收19.2元。      Top Gain / Loss Show All Charts     Value Name Updated Value Change Change % HSI 04-23 09:30 16682.7 ▲ 171 ▲ 1.04% GENSCRIPT BIO 04-25 16:09 10.76 ▲ 10.76 ▲ ∞% ≫More

Mobile | Full

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map

Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved

Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.